v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
 [1]
ASSETS    
Cash and cash equivalents $ 35,115 $ 13,395
Equity holdings 19,377 14,670
Property, plant and equipment, net 1,918 2,208
Assets of discontinued operations 133,267
Other assets 3,383 304
Total assets 59,793 163,844
LIABILITIES    
Accounts payable and accrued expenses 2,125 4,631
Short-term debt, net of issuance costs 1,775 1,923
Deferred income taxes, net 444 365
Liabilities of discontinued operations 129 10,134
Other liabilities 3,300
Total liabilities 4,473 20,353
Commitments and contingencies (Note 13)
STOCKHOLDERS’ EQUITY    
Series A Preferred Shares, $25.00 par and liquidation value, 10,000,000,000 shares authorized, 601,412 shares issued and outstanding as of September 30, 2026 and 888,884 shares issued and outstanding as of December 31, 2025 15,035 22,223
Common stock, $0.001 par value; 180,000,000,000 shares authorized, 8,735,799 issued and 4,594,068 outstanding as of September 30, 2026 and 8,698,994 issued and 7,080,747 outstanding as of December 31, 2025 [2] 70 70
Treasury stock (4,141,731 and 1,618,248 shares at cost as of September 30, 2026 and December 31, 2025, respectively) (48,900) (26,133)
Additional paid-in capital 217,089 216,682
Accumulated deficit (127,056) (68,743)
Accumulated other comprehensive loss (918) (608)
Total stockholders’ equity 55,320 143,491
Total liabilities and stockholders’ equity $ 59,793 $ 163,844
[1] Derived from the audited consolidated balance sheet.
[2] Information pertaining to the number of shares outstanding gives retroactive effect to a 1 for 5 reverse stock split that became effective on February 13, 2026.